Neuroscience Research Group (NEUROS), NeuroVitae Center. Institute of Translational Medicine (IMT). Escuela de Medicina y Ciencias de la Salud. Universidad del Rosario, Bogotá, Colombia.
Ophthalmology Interest Group, Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Universidad Del Rosario Escuela de Medicina y Ciencias de la Salud, Bogotá, Colombia.
BMJ Open Ophthalmol. 2023 Apr;8(1). doi: 10.1136/bmjophth-2023-001238.
To estimate the incidence and describe the demographic characteristics of keratoconus (KC) in Colombia using national health registry data between January 1st 2015 and December 31th 2020.
We conducted a nationwide, population-based study using the Integrated Social Protection Information System from the Colombian Ministry of Health, the unique official database in the country. We used the International Classification of Diseases code for KC (H186) to identify the number of new cases of KC and estimate the incidence rates both overall and according to age and sex. We made a standard morbidity ratio map to graph Colombia's morbidity risk of KC onset.
Of 50 372 424 subjects, 21 710 had KC between 2015 and 2020. However, due to the COVID-19 pandemic, all the incidence rates of this study were based on the 18 419 reported until 2019. The incidence rate in the general population was 10.36 (95% CI 10.08 to 10.64) per 100 000 inhabitants. The incidence peak among males was in their early 20s and females in their late 20s. The overall male to female incidence rate ratio was 1.60. Regarding the distribution of the disease, most cases were reported in Bogotá (48.64%), Antioquia (14.04%) and Cundinamarca (10.38%).
We performed the first nationwide, population-based study of KC in Latin America, finding distribution patterns similar to those reported in the literature. This study provides valuable information on the epidemiology of KC in Colombia, which is helpful in the development of policies for the diagnosis, prevention and treatment of the disease.
利用 2015 年 1 月 1 日至 2020 年 12 月 31 日期间的国家健康登记数据,估算哥伦比亚圆锥角膜(KC)的发病率并描述其人口统计学特征。
我们开展了一项全国性、基于人群的研究,使用了哥伦比亚卫生部的综合社会保护信息系统,这是该国唯一的官方数据库。我们使用国际疾病分类 KC 代码(H186)来确定 KC 的新发病例数量,并根据年龄和性别估算总体发病率和发病率。我们制作了标准发病比地图,以显示哥伦比亚 KC 发病风险。
在 50 372 424 名受试者中,2015 年至 2020 年间有 21 710 人患有 KC。然而,由于 COVID-19 大流行,本研究的所有发病率都基于截至 2019 年报告的 18 419 例。普通人群的发病率为 10.36(95%CI 10.08 至 10.64)/100 000 居民。男性发病率高峰在 20 多岁早期,女性在 20 多岁后期。总体男性与女性的发病率比值为 1.60。关于疾病的分布,大多数病例报告在波哥大(48.64%)、安蒂奥基亚(14.04%)和昆迪纳马卡(10.38%)。
我们进行了拉丁美洲首次全国性、基于人群的 KC 研究,发现了与文献报告相似的分布模式。这项研究为哥伦比亚 KC 的流行病学提供了有价值的信息,有助于制定疾病的诊断、预防和治疗政策。